Position in GILD
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$4,737,522,172
+$1,910,112,632 QoQ
Shares Held
33,992,410
+47.6% QoQ
Ownership
2.74%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 86.40379091696619.ToString("F0")%
Shared 0.10837419613302487.ToString("F0")%
None 13.48783488690078.ToString("F0")%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026JPMORGAN CHASE & CO holds $65,165,946,852 across 18 Drug Manufacturers - General names. GILD ranks #6 (7.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
63,096,344 | $15,423,270,317 | |
| 2 | LLY |
ELI LILLY & Co
|
13,698,491 | $12,599,461,057 | |
| 3 | ABBV |
AbbVie Inc.
|
56,741,691 | $12,340,750,365 | |
| 4 | MRK |
Merck & Co., Inc.
|
52,972,983 | $6,372,120,116 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
92,475,194 | $5,608,620,506 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
33,992,410 | $4,737,522,172 | |
| 7 | AZN |
Astrazeneca PLC
|
18,590,922 | $3,666,501,627 | |
| 8 | AMGN |
Amgen Inc
|
7,277,837 | $2,560,706,939 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,737,522,172 | 33,992,410 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $2,827,409,540 | 23,035,763 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $2,349,274,485 | 21,164,635 | Shares | Other | 2025-11-26 | |
| 2025-06-30 | $2,115,354,245 | 19,079,591 | Shares | Other | 2025-08-12 | |
| 2025-03-31 | $1,241,537,073 | 11,080,206 | Shares | Other | 2025-05-12 | |
| 2024-12-31 | $518,146,642 | 5,609,469 | Shares | Other | 2025-02-12 | |
| 2024-09-30 | $558,711,762 | 6,664,024 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $482,169,735 | 7,027,689 | Shares | Other | 2024-12-26 | |
| 2024-03-31 | $484,504,428 | 6,614,395 | Shares | Other | 2024-12-26 | |
| 2023-12-31 | $453,848,794 | 5,602,380 | Shares | Other | 2024-12-26 | |
| 2023-09-30 | $408,823,622 | 5,455,346 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $350,208,999 | 4,544,038 | Shares | Other | 2023-08-11 | |
| 2023-03-31 | $371,831,957 | 4,481,523 | Shares | Sole | 2023-05-18 | |
| 2022-12-31 | $420,720,711 | 4,900,649 | Shares | Other | 2023-02-13 | |
| 2022-09-30 | $310,302,543 | 5,030,030 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $329,601,818 | 5,332,500 | Shares | Other | 2022-08-11 | |
| 2022-03-31 | $338,311,514 | 5,690,690 | Shares | Other | 2022-05-11 | |
| 2021-12-31 | $229,892,911 | 3,166,133 | Shares | Other | 2022-02-11 | |
| 2021-09-30 | $165,832,974 | 2,374,130 | Shares | Other | 2021-11-12 | |
| 2021-06-30 | $239,430,759 | 3,477,066 | Shares | Other | 2021-08-12 | |
| 2021-03-31 | $232,365,783 | 3,595,324 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $214,443,574 | 3,680,803 | Shares | Other | 2021-02-19 | |
| 2020-09-30 | $174,947,005 | 2,768,587 | Shares | Other | 2020-11-12 | |
| 2020-06-30 | $213,404,470 | 2,773,648 | Shares | Other | 2020-08-11 | |
| 2020-03-31 | $530,485,439 | 7,095,846 | Shares | Other | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||